Hubei Biocause Pharmaceutical Market Cap

Hubei Biocause Pharmaceutical has a market cap or net worth of 19.56 billion as of January 3, 2025. Its market cap has increased by 32.89% in one year.

Market Cap

19.56B

Enterprise Value

42.99B

Revenue

40.70B

Ranking

n/a

PE Ratio

n/a

Stock Price

3.96

Market Cap Chart

Since March 21, 2005, Hubei Biocause Pharmaceutical's market cap has increased from 1.62B to 19.56B, an increase of 1,104.89%. That is a compound annual growth rate of 13.39%.

Market Cap History

Date	Market Cap	% Change
Jan 3, 2025	19.56B	-15.20%
Dec 31, 2024	23.07B	64.44%
Dec 29, 2023	14.03B	-10.13%
Dec 30, 2022	15.61B	-4.53%
Dec 31, 2021	16.35B	-32.03%
Dec 31, 2020	24.06B	-30.82%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
China Merchants Bank	983.28B
Ping An Insurance (Group) Company of China	883.53B
CITIC Securities Company	408.45B
East Money Information Co.,Ltd.	407.58B
Industrial Bank	398.04B
Shanghai Pudong Development Bank	302.03B
China Pacific Insurance (Group)	299.00B
Ping An Bank	227.05B

Market Cap Rankings